{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:32:25Z","timestamp":1777419145471,"version":"3.51.4"},"reference-count":53,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p> Minivelle\u00ae (Noven Therapeutics, LLC, FL, USA) is an estradiol transdermal delivery system that has recently been approved in the USA for prevention of postmenopausal osteoporosis. The decline in estrogen during menopause leads to bone resorption, increasing the risk of fractures. Transdermal estradiol has been shown to increase bone mineral density. Safety studies of transdermal estradiol have shown a decreased risk in cardiovascular disease as compared with oral estrogen therapy. Minivelle is currently the smallest available transdermal estradiol patch, providing the lowest effective dose of estrogen. <\/jats:p>","DOI":"10.2217\/whe.15.64","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T15:19:53Z","timestamp":1448896793000},"page":"815-824","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["The Smallest Available Estradiol Transdermal Patch: A New Treatment Option for the Prevention of Postmenopausal Osteoporosis"],"prefix":"10.1177","volume":"11","author":[{"given":"Abigail","family":"Bertonazzi","sequence":"first","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgette","family":"Nelson","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Salvador","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Umland","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"key":"bibr1a-whe.15.64","unstructured":"Papers of special note have been highlighted as:"},{"key":"bibr2a-whe.15.64","unstructured":"of interest; \u2022\u2022 of considerable interest."},{"key":"bibr1-whe.15.64","volume-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","author":"National Osteoporosis Foundation","year":"2014"},{"key":"bibr2-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070902"},{"key":"bibr3-whe.15.64","volume-title":"Vivelle-Dot [prescribing information]","year":"2014"},{"key":"bibr4-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2010.02.014"},{"key":"bibr5-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0646"},{"key":"bibr6-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1206"},{"key":"bibr7-whe.15.64","volume-title":"Minivelle Clinical Review","author":"Price P","year":"2014"},{"key":"bibr8-whe.15.64","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2013.771520"},{"key":"bibr9-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000137833.43248.79"},{"key":"bibr12a-whe.15.64","unstructured":"Important randomized, placebo-controlled trial demonstrating the improvement in bone mineral density with use of low-dose transdermal estradiol."},{"key":"bibr10-whe.15.64","first-page":"7","volume":"7","author":"Inderjeeth CA","year":"2015","journal-title":"Int. J. Womens Health"},{"issue":"5","key":"bibr11-whe.15.64","first-page":"579","volume":"78","author":"Holder KK","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"bibr12-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0493-y"},{"key":"bibr13-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181bdce0a"},{"key":"bibr14-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-13-36"},{"key":"bibr15-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405"},{"key":"bibr16-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1998"},{"key":"bibr17-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.10.1140"},{"key":"bibr18-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1707"},{"key":"bibr19-whe.15.64","unstructured":"Estradiol (Systemic). McGraw Hill Medical: Access Medicine. http:\/\/accessmedicine.mhmedical.com."},{"key":"bibr20-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1701"},{"key":"bibr21-whe.15.64","unstructured":"Estradiol. American Hospital Formulary Service Drug Information. American Society of Health System Pharmacists, Bethesda, MD, USA, 1604\u20131612 (2009)."},{"key":"bibr22-whe.15.64","volume-title":"Minivelle [prescribing information]","year":"2014"},{"key":"bibr26a-whe.15.64","unstructured":"US FDA-approved package insert."},{"key":"bibr23-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200209000-00007"},{"issue":"3","key":"bibr24-whe.15.64","first-page":"330","volume":"99","author":"Weiss SR","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"bibr29a-whe.15.64","unstructured":"Trial of varying doses of transdermal estradiol in the prevention of postmenopausal osteoporosis."},{"key":"bibr25-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.637459.x"},{"key":"bibr26-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.936377"},{"key":"bibr27-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4470"},{"key":"bibr28-whe.15.64","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Levin ER","year":"2011","edition":"12"},{"key":"bibr29-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.642280"},{"key":"bibr35a-whe.15.64","unstructured":"Important case\u2013control study demonstrating no increased risk of venous thromboembolism in transdermal estrogen users compared with nonusers."},{"key":"bibr30-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007497"},{"key":"bibr31-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2011.2839"},{"key":"bibr32-whe.15.64","unstructured":"Liu J, Minkin MJ. Advances in transdermal estrogen-only therapy for vasomotor symptoms. Clin. Rev. S1\u2013S12 (2013)."},{"key":"bibr33-whe.15.64","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S937"},{"key":"bibr40a-whe.15.64","unstructured":"Review of the role of transdermal hormone delivery systems in preventing postmenopausal osteoporosis."},{"key":"bibr34-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31818ebfba"},{"key":"bibr35-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32833c07bc"},{"key":"bibr43a-whe.15.64","unstructured":"Key review of recent findings regarding venous thromboembolism risk in transdermal estradiol users compared with oral estrogen users."},{"key":"bibr36-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.47"},{"key":"bibr37-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000428645.90795.d9"},{"key":"bibr38-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2011.03.011"},{"key":"bibr39-whe.15.64","first-page":"232","volume":"38","author":"Marigarido PF","year":"2011","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"bibr40-whe.15.64","doi-asserted-by":"publisher","DOI":"10.4158\/EP.17.S6.1"},{"key":"bibr41-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem031"},{"key":"bibr42-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39555.441944.BE"},{"key":"bibr43-whe.15.64","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3182175e5c"},{"key":"bibr44-whe.15.64","volume-title":"Vivelle [prescribing information]","year":"2000"},{"issue":"2","key":"bibr45-whe.15.64","first-page":"257","volume":"19","author":"Schmidt P","year":"2012","journal-title":"Menopause"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.64","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/whe.15.64","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.64","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:17:31Z","timestamp":1741616251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/whe.15.64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.2217\/whe.15.64"],"URL":"https:\/\/doi.org\/10.2217\/whe.15.64","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"value":"1745-5057","type":"print"},{"value":"1745-5065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}